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ABSTRACT
Introduction: In the past two decades, childhood
vaccination coverage has increased dramatically,
averting an estimated 2–3 million deaths per year.
Adult vaccination coverage, however, remains
inconsistently recorded and substandard. Although
structural barriers are known to limit coverage, social
and psychological factors can also affect vaccine
uptake. Previous qualitative studies have explored
beliefs, attitudes and preferences associated with
seasonal influenza (flu) vaccination uptake, yet little
research has investigated how participants’ context and
experiences influence their vaccination decision-making
process over time. This paper aims to provide a
detailed account of a mixed methods approach
designed to understand the wider constellation of
social and psychological factors likely to influence
adult vaccination decisions, as well as the context in
which these decisions take place, in the USA, the UK,
France, India, China and Brazil.
Methods and analysis: We employ a combination
of qualitative interviewing approaches to reach a
comprehensive understanding of the factors
influencing vaccination decisions, specifically seasonal
flu and tetanus. To elicit these factors, we developed
the journey to vaccination, a new qualitative approach
anchored on the heuristics and biases tradition and the
customer journey mapping approach. A purposive
sampling strategy is used to select participants who
represent a range of key sociodemographic
characteristics. Thematic analysis will be used to
analyse the data. Typical journeys to vaccination will be
proposed.
Ethics and dissemination: Vaccination uptake is
significantly influenced by social and psychological
factors, some of which are under-reported and poorly
understood. This research will provide a deeper
understanding of the barriers and drivers to adult
vaccination. Our findings will be published in relevant
peer-reviewed journals and presented at academic
conferences. They will also be presented as practical
recommendations at policy and industry meetings and
healthcare professionals’ forums. This research was
approved by relevant local ethics committees.
BACKGROUND
In the past two decades, childhood vaccin-
ation coverage has increased dramatically,
averting an estimated 2–3 million deaths per
year, along with myriad episodes of illness
and disability.1 2 Adult vaccination coverage,
however, remains poorly recorded and
substandard.2 3
Two important adult routine vaccines are
seasonal inﬂuenza (ﬂu) and tetanus-
containing vaccines.4 An annual ﬂu vaccine
is recommended to all adults, particularly
those aged ≥65 years and under 65 years
with certain medical conditions such as
asthma, heart disease and diabetes. Despite
this recommendation, in any given year, ﬂu
epidemics can cause between 500 000 and
1 000 000 deaths globally.5 A tetanus-
containing booster is recommended every
10 years to prevent tetanus and other dis-
eases such as pertussis, diphtheria and polio.
Although tetanus morbidity and mortality is
mostly neonatal and maternal, globally, an
estimated 13 000 annual non-maternal adults
deaths are due to tetanus infection.6
Moreover, it has been established that unvac-
cinated adolescents and adults, or those with
waning immunity, have become a major
source of pertussis infection for unvaccinated
infants.7 The WHO estimated that, in 2008,
195 000 children under 5 years of age died
from pertussis and 199 000 from ﬂu, many of
whom were infected by an adult.8
Although structural barriers, such as access
to care and vaccine availability, are known to
Strengths and limitations of this study
▪ The journey to vaccination, a multidisciplinary
qualitative approach, is used to elicit underlying
beliefs, attitudes and preferences affecting vac-
cination decisions.
▪ A multinational and relevant sample population
will be recruited.
▪ The interview schedules and local interviewers’
training are standardised, which will enable data
comparability.
▪ Challenges in recruiting specific participant cat-
egories may be encountered and cross-cultural
variations will need to be documented and
explained.
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limit coverage, social and psychological factors can also
affect vaccine uptake. For example, perceived suscepti-
bility to ﬂu and concerns about vaccine safety and effect-
iveness have been shown to signiﬁcantly inﬂuence
vaccination behaviour.9 10 The relevance of these factors
to vaccination decisions has become a focus of policy dis-
cussions, such that national and supranational immun-
isation advisory committees are now evaluating how to
best measure conﬁdence in vaccines to inform and
evaluate future interventions.11
Making decisions about our own health in general, and
vaccinations in particular, can be a difﬁcult task.
Typically, it involves navigating an often intricate health-
care system, discussing the issue with a healthcare profes-
sional (HCP), researching the Internet, consulting family
members and peers and trying to make sense of all the
available information, which is likely to be incomplete
and conﬂicting.12 A key challenge in decision-making
processes regarding health is weighing up the beneﬁts of
an intervention versus its potential harm. In the case of
vaccinations, this process can be particularly complex as
it often entails the assessment of several disease-related
variables including severity, likelihood of catching the
pathogen and susceptibility to it, as well as vaccine attri-
butes such as effectiveness, side effects and safety, among
others.13 Furthermore, the beneﬁts and drawbacks of vac-
cines are normally conveyed in statistical terms, a lan-
guage that has proven to be difﬁcult to grasp for most
people. For example, results from an experimental study
showed that 16–20% of highly educated participants
incorrectly answered relatively simple questions about
risk magnitudes (eg, Which represents the larger risk:
1%, 5% or 10%?).14 It is, therefore, conceivable that a sig-
niﬁcantly larger proportion of less-educated individuals,
who constitute a majority of the population, are likely to
misunderstand this type of data.
A vast body of research has demonstrated that when
people are unable to assess risk using statistical reason-
ing they often rely on heuristics, an experience-based
and intuitive approach used to facilitate decision-
making.15–17 Heuristics represent what psychologists
have termed ‘cognitive shortcuts’; in other words, they
allow an inference to be made regarding risk without
going through numerous analytical calculations. By its
very nature, the use of heuristics can be efﬁcient and
accurate in some occasions, but it can also lead to cogni-
tive errors and ﬂawed decision-making when used in cir-
cumstances that require thorough logical analysis.18
Furthermore, individuals’ judgement is often inﬂuenced
by their context and personal or family experiences,
whether these are conscious or not.19 Health decisions
in general, and vaccination decisions in particular, can
also be signiﬁcantly inﬂuenced by patients’ trust in
HCPs and the latter’s ability to communicate risk
effectively.20
Although qualitative studies have explored beliefs, atti-
tudes and preferences associated with ﬂu vaccination
uptake, thus far, little research has investigated how
participants’ own context and experiences inﬂuence
their vaccination decision-making process over time.21–23
Furthermore, most studies focus on populations from
developed countries; relevant evidence from developing
countries is largely missing. Qualitative research on
adult tetanus boosters is limited and focuses on neonatal
tetanus.
This paper aims to provide a detailed account of a
mixed method qualitative approach designed to under-
stand the wider constellation of social and psychological
factors likely to inﬂuence adult vaccination behaviour,
and their relative importance, as well as the context in
which these decisions take place. Our focus is on social
inﬂuences, beliefs and attitudes affecting the uptake of
seasonal ﬂu vaccines and tetanus boosters, as these
aspects have been found to be particularly inﬂuential in
vaccination decision-making. Our research will be con-
ducted in key developed and developing economies—
the USA, the UK, France, India, China and Brazil.
CONCEPTUAL FRAMEWORK
Our research sits well within the constructivist (or inter-
pretivist) paradigm, which is concerned with people’s
experiences from the perspective of those who live
them, and whereby the researcher and participant
‘jointly create ﬁndings from their interactive dialogue
and interpretation’.24 From an epistemological point of
view, however, our position draws from constructivism
and positivism, in that we recognise there is a degree of
bias introduced by the researcher’s experience when
creating knowledge, but the researcher will endeavour
to be objective and to elicit the participant’s experience
in an unprejudiced manner.25
The methodology of this study rests on two theoretical
approaches: heuristics and biases, speciﬁcally the availability
heuristic26 and customer journey mapping.27–29 We explain
these below.
As mentioned in the previous section, people rely on
a limited number of heuristics which reduce the com-
plexity of calculating probabilities and predicting out-
comes to simpler mental operations. A frequently used
heuristic is availability, the tendency to make judgements
about the frequency or probability of an event based on
the ease with which a similar episode can be recalled.30
The use of this heuristic could yield accurate actions but
it could also lead to erroneous decisions. For example, a
high-risk individual may be prompted to have a ﬂu
vaccine after being exposed to extensive media coverage
about one single ﬂu-related death. The following season,
he may decide not to have the ﬂu vaccine due to a
friend experiencing side effects (eg, ﬂu-like symptoms)
after receiving a ﬂu vaccine. In both cases, his decision-
making is determined by the ease with which the risks
associated with ﬂu or the ﬂu vaccine spring to mind
(which vary between the two seasons), as opposed to the
statistical probability of experiencing either adverse
effect (which may be constant across the two seasons).
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The ﬁrst decision, however, is aligned with current vac-
cination recommendations, whereas the second is not.
In addition, it has been established that people’s
evaluation of the logical strength of an argument is
often biased by their pre-existent belief in the truth or
falsity of the conclusion.31 For example, if the same
high-risk individual distrusts the medical establishment
and the pharmaceutical industry and prefers alternative
medicine instead, it is likely that the news about a
ﬂu-related death will have a lesser impact on his vaccin-
ation decision than his friend’s reported side effects—
due to mentally overweighting the adverse effects of the
vaccine, which are consistent with his pre-existing
beliefs. Importantly, belief-based decision-making need
not be conscious.32 33 Thus, a decision based on intu-
ition may be later postrationalised and explained using
analytical-sounding arguments, when, in reality, cost–
beneﬁt analysis was not employed.
The customer journey mapping approach is com-
monly used in service design to capture and evaluate
people’s experience of different services. Although some
elements may be more important than others, this
approach considers the overall experience of the service
user as the result of every element in a journey through
a service. The customer journey mapping approach has
been mainly used by the transport and tourism indus-
tries, yet it has also enabled health providers to improve
their services by uncovering key areas which deserve
attention and focus improvement efforts on such
areas.34 Of particular note is the brand touchpoint wheel
developed a decade ago by Dunn and Davies.35 They
conceive the customer journey as a wheel comprising
three main stages (prepurchase, purchase and post-
purchase experience) and a number of touchpoints,
which are key points at which the consumer interacts
with a particular product or service (see ﬁgure 1).
Our approach: journey to vaccination
Most qualitative studies in the ﬁeld of vaccination
decision-making have elicited barriers and enablers to
vaccination using traditional methodological approaches
such as explicit enquiry (eg, why did you vaccinate?)
and indiscriminate use of probes, often within a focus
group setting. A key shortcoming of these approaches is
that the impact of individuals’ personal circumstances
and past experiences on vaccination decisions over time
is seldom explored. Thus, researchers may fail to notice
participants’ tendency to fall back on readily available
information and report postdecisional rationalisations of
their behaviours rather than actual drivers.
In an effort to address these shortcomings, we devel-
oped a new qualitative approach which we call journey to
vaccination. Anchored on the two complementary lines
of thought described above and nested within the quali-
tative research tradition, journey to vaccination is a
visual exercise in which the interviewer and the partici-
pant jointly build a timeline that captures salient events
that lead the participant to get or not to get vaccinated.
The exercise starts with a participant’s latest ﬂu or
tetanus vaccination experience as an adult; it then
extends backwards to the participant’s ﬁrst memory of
such experience. The participant is asked to describe
these events, which in turn allows the interviewer to
indirectly elicit a range of factors that affected positively
or negatively the decision to get vaccinated. Importantly,
this exercise enables the participant to produce a per-
sonal historical narrative, through which vaccination
decisions are discussed as a continuum and not in isola-
tion from each other or from other important
health-related or lifestyle-related decisions.
The journey to vaccination approach is designed to
comprehensively capture psychological and also social
inﬂuences on vaccination decisions. Participants are,
therefore, asked to recall key actors who were involved
in the vaccination process (eg, their family) and how
they inﬂuenced the process. Emotional aspects of the
decision-making are also explored and taken into
account.
On the basis of the customer journey mapping approach
described earlier and previous evidence on vaccination
behaviour, we envisage a journey to vaccination to comprise
three stages and a number of touchpoints at which the
individual interacts with related health services (ﬁgure 2):
(1) prevaccination period (appointment with HCP, infor-
mation—websites, news, vaccination campaigns, peers—
and HCP reminders); (2) the vaccination experience itself
(location, consultation experience and vaccination experi-
ence) and (3) a postvaccination experience (vaccine
quality—eg, side effects, effectiveness—and postvaccination
advice or information—from HCP, peers and other
sources).10 35 36 An important component of a journey to
vaccination is a cue to action or trigger, which consists of
an internal or external stimulus (eg, salient health-related
experiences, advice from a relative) that prompts indivi-
duals to vaccinate or not to vaccinate. Existing evidence
suggests that vaccination triggers may usually take place
during the prevaccination stage and could sometimes
overlap with vaccination touchpoints.10 For example, a vac-
cination reminder letter from the general practitioner
would be a trigger and a touchpoint, if participants expli-
citly mention that the letter prompted them to vaccinate.
Figure 3 illustrates a journey to ﬂu non-vaccination of
a participant from a UK pilot (see Procedure section)
who is not at high risk (ie, not eligible for free vaccin-
ation). The participant mentioned that an allergy to
penicillin discovered when he was younger, which his
doctor refused to acknowledge, had made him anxious
about other medications’ side effects, including vaccines.
This was recorded as the ﬁrst relevant touchpoint and
trigger away from vaccination. He then pointed out that
some time ago he had heard on the news that there had
been ﬂu-related deaths, and that this had been a cause
for concern which made him consider having a ﬂu shot
(another touchpoint and trigger to vaccination).
Subsequently, he recalled having the ﬂu and worrying
about the consequences of being out of work due to his
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self-employed status (trigger to vaccination). The partici-
pant then reported that at that stage he had tried to get
a ﬂu vaccine at a pharmacy, but it was out of stock
(touchpoint and trigger away from vaccination). Finally,
the participant remembered that the vaccine could have
side effects and decided to stop trying to get vaccinated
(trigger away from vaccination). This journey, therefore,
does not include a postvaccination stage. Importantly,
analysis of the participant’s account of his journey to
non-vaccination indicates a tendency to make decisions
based on heuristics rather than logical analyses. For
example, the participant’s motivation to have a ﬂu shot
Figure 1 The brand touchpoint wheel. Source: Dunn and Davis.35
Figure 2 Journey to vaccination.
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after hearing on the news about ﬂu-related deaths was
based on the mental availability of this piece of informa-
tion and not his actual risk of death from ﬂu.
STUDY AIMS
The primary aim of this study was to gain deeper under-
standing of the social and psychological factors
inﬂuencing the uptake of two different adult vaccines
across key high-income and middle-income countries
with diverse healthcare systems: the USA, the UK,
France, India, China and Brazil. Speciﬁcally, we are
interested in exploring how people’s experiences shape
their beliefs, attitudes and behaviour towards vaccines. A
secondary objective was to develop more effective
methods to elicit such data.
METHODS
Setting
This research is conducted in six countries, in urban,
sparsely populated towns and rural areas of the following
states or regions: New York, New Jersey and Illinois
(USA); West Midlands, London and South East (UK);
Nord Pas-de-Calais and Île-de-France (France);
Maharashtra and Karnataka (India); Shanghai and
Guangzhou (China) and São Paulo and Rio de Janeiro
(Brazil).
Sampling and recruitment
A purposive sampling strategy is used to select adult
participants who are vaccinated and not vaccinated
against ﬂu and tetanus, and represented a range of
sociodemographic characteristics associated with vaccin-
ation uptake, notably age and health status (see
table 1). In an effort to reduce recall bias,11 only those
who have been vaccinated in the past 12 months are eli-
gible to participate. Potential participants are selected
at random from current telephone directories. For con-
sistency, a minimum of 20 participants are recruited
per country, an acceptable sample size for a qualitative
study.37
We prioritise unvaccinated participants who state that
they will either deﬁnitely or probably get vaccinated
against ﬂu or tetanus ‘one day’ or that they will probably
not get vaccinated against ﬂu or tetanus, as these
Figure 3 Example of a journey to flu non-vaccination.
Table 1 Purposive sampling strategy
Key demographic
characteristics
Minimum participant
quota per country
Eligible chronic condition* 7 with
7 without
Gender 8 females
8 males
Parent/guardian of child/
children under 18
4 mothers
4 fathers
Age 8 18–49
4 50–64
6 ≥65
Socioeconomic group (social
grade)†
7 ABC1
7 C2DE
Adults who have had ONE of
the vaccines
4 flu
3 tetanus
Have had tetanus and flu
vaccines
6
Have not had either
vaccination
6
Urban/rural‡ 5
Total 20
*These include asthma, chronic obstructive pulmonary disease or
bronchitis, heart disease, kidney disease, liver disease,
neurological conditions, weakened immune system due to
conditions such as HIV and AIDS, or as a result of medication
such as steroid tablets or chemotherapy.
†A=higher socioeconomic group and E=lower socioeconomic
group. We used country-specific occupation and income data to
determine participants’ social grade.
‡The urban/rural quotas for the UK and France were relaxed due
to the quality and coverage of their public health systems.
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attitudes are representative of the majority of the non-
vaccinated population.38 This is carried out via the fol-
lowing screening question at the time of recruitment:
“Which of the following statements most closely reﬂects
your attitude to the ﬂu and tetanus vaccinations? (1) I
will deﬁnitely get vaccinated against ﬂu or tetanus one
day; (2) I will probably get vaccinated against ﬂu or
tetanus one day; (3) I will probably not get vaccinated
against ﬂu or tetanus; (4) I will deﬁnitely not get vacci-
nated against ﬂu or tetanus.”
Procedure
The data collection is carried out jointly by the ﬁrst
author (UK and USA) and Ipsos MORI, a multinational
market research ﬁrm and their associates. Interviewers
have been trained either face-to-face or via teleconfer-
ence (USA) by Ipsos MORI researchers. They have also
been provided with a manual containing detailed inter-
view instructions. Interview guides and materials have
been translated into French (France), Hindi, Marathi
and Kannada (India), Chinese (China) and Portuguese
(Brazil) by the local research teams. Participants are
interviewed face-to-face in their native language for
approximately 60 min at home or a central interviewing
facility and interviews are digitally recorded. Participants
are fully informed about the study via a participant
information sheet. Written consent is obtained and each
participant receives an equivalent of £11–£78 incentive,
depending on the country and location of the interview,
in return for their time. Before starting each interview,
participants are reminded about the strict conﬁdentiality
of their responses.
A prepilot was conducted with N=4 (two researchers
from Imperial College London and two from Ipsos
MORI not involved in the present study) to test duration
and ﬂow of the interview. Consequently, the interview
guide was simpliﬁed and shortened. These interviews
will not be included in the ﬁnal sample for analysis. A
piloting technique was subsequently used for the ﬁrst
three interviews in the UK, whereby the research team
observed each interview behind a one-way mirror and
evaluated its quality in real time. At the end of the
session, minor amendments to the interview guide were
agreed and the ﬁnal interview materials produced.
We use two semistructured and probing interview
schedules, one for vaccinated and the other for non-
vaccinated participants, constructed through expert con-
sultations and a literature review10 (see table 2). We
employ a combination of interviewing techniques to
reach a comprehensive understanding of the factors
underpinning vaccination decisions. The schedule com-
prises six sections as follows.
Section 1 aims to obtain an overview of participants’
life and values, to build rapport and to identify import-
ant issues to assist with probing throughout the
interview.
Section 2 aims to elicit participants’ general
information-seeking behaviours and inﬂuences. We
explore information sources (eg, media, family, peers,
etc) through which people’s knowledge about and atti-
tudes towards vaccines may be formed.
Section 3 examines participants’ views towards health,
HCPs and adult vaccines. This section aims to under-
stand how people’s perceptions towards their own health
and their relationship with HCPs inﬂuence their stance
on vaccines. General views on adult vaccines are evalu-
ated by asking participants to arrange ﬁve adult vaccin-
ation cards (ﬂu, tetanus, pneumonia, hepatitis and
measles, mumps and rubella) into one or more groups.
By identifying how people group vaccines, and the
reasons for their groupings, we aim to contextualise and
gain deeper understanding of their views on ﬂu vaccines
and tetanus-containing boosters.
Section 4 explores participants’ journeys to vaccination
(or non-vaccination) for ﬂu vaccines and tetanus-
containing boosters. We aim to undertake an indepth
exploration of the vaccination decision-making process
by identifying important aspects that lead people to vac-
cinate or not to vaccinate.
In an effort to circumvent availability bias, we avoid
asking direct questions such as ‘Why did you have a ﬂu
shot?’ Instead, we explore the set of circumstances and
emotions that drive participants to accept or refuse vac-
cination, aided by an elicitation technique called ladder-
ing, which provides a simple and systematic way of
establishing people’s core values and beliefs, and the lin-
kages between these and key behaviours, in this case,
vaccination.39 To minimise postrationalisation, we do not
use probes in this section of the interview.
Section 5 of the interview examines participants’ attitudes
towards children’s vaccinations. We aim to understand
whether people’s views about adult vaccines correspond
with their views about children’s, and if so, how.
Finally, in section 6, we explore participants’ knowl-
edge of the two diseases and vaccines (ie, ﬂu and
tetanus) to understand to what extent their decision-
making is inﬂuenced by facts.
Key sociodemographic information is collected at the
end of the interview—including employment status,
occupation, health insurance, perceived ability to afford
essential goods, level of education, marital status, reli-
gion and ethnicity.
Data analyses
The recorded interviews are professionally transcribed
and translated into English, and checked for accuracy by
Ipsos MORI. To ensure reliability of coding and inter-
pretation, all the transcripts will be analysed by one aca-
demic researcher (AW) and 50% of the transcripts will
be analysed independently by a second researcher.40
Differences will be resolved through dialogue until con-
sensus is reached. Using thematic analysis, an initial cate-
gorising system will be developed based on the study
objectives and the topics explored.41 42 New themes and
subthemes emerging from the data analysis will be iden-
tiﬁed and included when consensus is reached
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regarding their relevance. A ﬁnal thematic index will be
produced to code all data—and verbatim quotes to
support the extracted themes will be tabulated. In add-
ition, a journey to vaccination for ﬂu and other for
tetanus will be produced for each participant.
Differences and commonalities emerging from these
data will be identiﬁed and synthesised, and, if possible,
typical journeys will be proposed.
Ethics and dissemination
This is a collaborative study designed and undertaken by
Imperial College London (academic partner), Sanoﬁ
Pasteur (commercial partner) and Ipsos MORI (market
research partner). A steering group comprising Imperial
College London senior researchers, Sanoﬁ Pasteur direc-
tors and Ipsos MORI research directors provide ongoing
academic input, project management and strategic
direction.
Ipsos MORI follows the European Society of Market
Research Organisations (ESOMAR) Code of Conduct
for international ﬁeldwork. This research is also carried
out in accordance with the requirements of the inter-
national quality standard for market research, ISO
20252:2006, International general company standard
ISO 9001:2008 and International standard for informa-
tion security ISO 27001:2005.
The nature of the research topic and the sample
(general population) make this study one with few
ethical issues. However, we recognise that all participants
should be willing and able to participate in this study
and that there is a small possibility that respondents may
disclose information that could potentially cause
Table 2 Interview schedule
Interview topic (sections 1–6) Key interview questions
1. Overview of life and values ▸ Tell me about yourself and your life, for example, what you spend your time
doing and how you enjoy yourself
▸ What sorts of things do you worry about?
2. Information-seeking behaviours and
influences
▸ Can you tell me how you find out what is happening generally in the world?
▸ And who are the people whose opinion you value or with whom you discuss
important issues with? And why is that?
3. Views about health and vaccinations ▸ Can I ask how you feel your own health is?
▸ When you think about your health, what are all the things that come to mind?
Do you do anything to keep healthy? What sorts of things?
▸ Which doctors or nurses do you particularly trust and listen to, if any? And
why is that? Why is that important to you?
▸ Thinking now about vaccinations, what are all the things that come to mind
when you think about vaccinations?
▸ Looking at these cards, which are all adult vaccinations, please can you sort
them into groups?
4. Journey to vaccination (or
non-vaccination)
▸ How would you describe to a friend how you came to have (or not to have)
the vaccination? What things happened that meant you ended up getting (or
not getting) vaccinated?
▸ What would you say happened at that point that triggered that change (or
decision)? And why was that important?
▸ How did you know where to go for the vaccination? How did you book an
appointment and fit it into your plans? What other things were competing for
your time?
▸ Before you were vaccinated, do you remember any times when you thought
about or started the process towards being vaccinated but did not end up
getting vaccinated? (vaccinated)
▸ Of all of those things, which would you say was the most important thing that
led to you not getting vaccinated? And why is that? And the second most
important thing? And the third? (non-vaccinated)
5. Children’s vaccinations ▸ In general, do you think people should vaccinate their children against
tetanus? Why/why not?
▸ And do you think people should vaccinate their children against flu? Why/why
not?
6. Factual knowledge on flu and tetanus
and related vaccines
▸ How much would you say you know about flu/tetanus? How serious or
life-threatening do you think the disease is? In general, how likely do you
think you are to catch the disease?
▸ How much would you say you know about the vaccine for flu/tetanus? Do you
happen to know how often it is recommended that you have it, or who it is
recommended for?
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psychological distress for the individual if the purposes
of the research are misunderstood. To address these
issues, all participants are informed about the purposes
of the research and written consent is obtained from the
participants prior to their involvement in the study.
Furthermore, when designing the interview schedule,
there has been due consideration to the phrasing of the
questions so as not to attribute blame, for example, for
not carrying out responsible duties associated with parti-
cipants’ own health or that of the general public.
Our ﬁndings will be disseminated to relevant policy,
industry, clinical and academic audiences through differ-
ent outlets. These will be presented as practical recom-
mendations at policy and industry meetings and HCPs’
forums. Our results will also be presented at academic
conferences and published in peer-reviewed journals.
CONCLUSION
Vaccination uptake is signiﬁcantly inﬂuenced by a con-
stellation of social and psychological factors. In order to
capture these factors, and to understand their relative
importance, we need to go beyond readily available, and
in some cases, postrationalised responses, and explore
underlying motivations which may be driving vaccination
behaviour. This study combines qualitative techniques,
service design and psychology theories to develop the
journey to vaccination, a new approach aimed at under-
standing vaccination decision-making processes across
time. The journey to vaccination approach will allow us
to explore how people’s beliefs and attitudes towards
vaccination are shaped by their context and experiences,
and to evaluate whether vaccination decision-making is
driven by heuristic judgement, logical analysis or both,
and to what extent.
The global scope of this research will allow us to
perform cross-cultural comparisons, which will in turn
shed light on key internal (eg, beliefs, perceptions) and
external (eg, HCP advice, vaccine availability, cost)
stimuli which inﬂuence vaccination behaviour across dif-
ferent vaccines, geographies and populations. Our ﬁnd-
ings can provide a deeper understanding of the barriers
and drivers to adult vaccination, which may in turn lead
to more effective interventions.
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